Zehbe I, Wilander E
Department of Pathology, University Hospital, Uppsala, Sweden.
Hum Pathol. 1996 Aug;27(8):812-5. doi: 10.1016/s0046-8177(96)90454-2.
Polymerase chain reaction (PCR) is being increasingly used in clinical laboratories for the diagnosis of human papillomavirus. From the L1 region, there are two commonly used consensus primer systems designated CP5+/G6+ and MY09/MY11. Both detect a wide variety of human papillomaviruses (HPVs). In this investigation, the authors compared the sensitivity of these approaches with the modification of hot-start PCR on 148 neutral-buffered formaldehyde-fixed cervical biopsies classified as cervical intraepithelial neoplasia (CIN) I to III. The authors chose hot-start PCR because in a previous study it proved more sensitive than cold-start PCR. Furthermore, the authors combined GP5+/GP6+ and MY09/MY11 in a two-step amplification (nested PCR) to analyze further those cases that proved negative with either GP5+/GP6+ or MY09/MY11. The authors found that the two consensus primer systems were equally sensitive with a correlation of 98%. By using GP5+/GP6+, the authors achieved an HPV positivity rate of 95% and with MY09/MY11 94%. Nested PCR did not improve HPV positivity in the CINs included in this study.
聚合酶链反应(PCR)在临床实验室中越来越多地用于诊断人乳头瘤病毒。从L1区域来看,有两种常用的共有引物系统,分别为CP5+/G6+和MY09/MY11。两者都能检测多种人乳头瘤病毒(HPV)。在本研究中,作者比较了这两种方法以及热启动PCR改良法对148例经中性缓冲甲醛固定、分类为宫颈上皮内瘤变(CIN)I至III级的宫颈活检组织的检测敏感性。作者选择热启动PCR是因为在之前的一项研究中它被证明比冷启动PCR更敏感。此外,作者将GP5+/GP6+和MY09/MY11组合用于两步扩增(巢式PCR),以进一步分析那些用GP5+/GP6+或MY09/MY11检测为阴性的病例。作者发现这两种共有引物系统的敏感性相同,相关性为98%。使用GP5+/GP6+时,作者获得的HPV阳性率为95%,使用MY09/MY11时为94%。巢式PCR并未提高本研究中所纳入的CIN患者的HPV阳性率。